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Ultrasonographic Risk Score of Carotid Plaques
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R. Fernandes e Fernandes, T. F. Carneiro and C. Balsinha
Instituto Cardiovascular de Lisboa, Lisboa, Portugal
Objective: to determine the relative significance of ultrasonographic parameters of carotid plaques to develop an Activity
Index (AI) which could correlate with clinical findings.
Method: two hundred and fifteen plaques in 141 patients underwent ultrasonography and computer-assisted structural
analysis. In half the patients (group 1), plaques were classified as either homogeneous and heterogeneous and ultrasono-
graphic appearances related symptomatic (SP) or asymptomatic (AP) station. The probability of SP for each ultrasound
parameter was used to define an Activity Index (AI). The AI was then applied the second half of patients (Group 2) to assess
the value of AI in determining symptomatic station.
Results: the parameters with highest morbility were surface disruption, severe stenosis and low grey scale median and,
additionally in heterogenous plaques heterogeneity and the presence of a juxta-luminal echolucent area. The power in group
2 of AI to identify symptomatic plaques was determined. Mean AI was for SP-75 (41±100) and for AP-43 (22±100); 78% of
SP have AI4 60 and 70% of AP have AI5 50. The cut-off point between the two groups was 52. ROC curve analysis of
the AI were obtained to determine its diagnostic accuracy.
Conclusion: Activity Index is an objective parameter of plaque echostructure that positively correlates with symptoms. AI
may contribute to better selection for treatment of patients with carotid artery disease.
Key Words: Carotid plaque; Carotid plaque risk score; Computer-assisted plaque analysis; High-risk carotid plaque;
High definition ultrasonography.
Introduction
Carotid bifurcation plaques may cause neurological
symptoms because of distal embolisation or flow
reduction. Data from several published studies point
out the importance of the degree of stenosis as a major
determinant of stroke, in both symptomatic and
asymptomatic disease.1±3 However, other factors of
plaque structure and composition can also be impor-
tant, as suggested by histopathological and non-
invasive studies.4±21 In a previous investigation22 we
have suggested that ultrasonographic parameters in
association with the degree of stenosis, were impor-
tant determinants of a profile of unstable carotid
plaques associated with neurological symptoms.
The aim of the present study was to quantify the
relative weight and importance of each significant
parameter assessed from ultrasonographic evaluation
and to obtain an Activity Index (AI), which could
correlate with the presence of associated ipsilateral
symptoms. The diagnostic accuracy of this AI was
also assessed prospectively in a separate group of
plaques.
Material and Method
The study included 215 carotid bifurcation plaques
from 141 patients, 105 males and 36 females.
Patients were observed consecutively and the clinical
investigation included a neurological consultation and
a brain CT scan. A plaque was considered symptom-
atic when accompanied by Amaurosis fugax or by focal
transitory, reversible or established neurological
symptoms in the ipsilateral carotid territory, in
the previous 6 months. The CT scan was analysed by
a neuroradiologist and considered positive when
evidence of cerebral infarction was present in the
appropriate hemisphere. Lacunar infarctions were
excluded. Arterial hypertension was present in 73%,
Diabetes mellitus in 25%, smoking habits in 60%,
dyslipidemia in 43%, ischaemic heart disease in
39% and evidence of lower limb occlusive disease in
37%. The mean age was 68 years (41±87).
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The cohort of plaques was randomly divided in two
groups: 106 plaques in 74 patients (Group 1) were
used to determine the value of significant diagnostic
parameters derived from the echostructure of the
lesions and for construction of an Activity Index
(AI). Subsequently, AI was applied on the 109 plaques
in 67 patients (Group 2) to assess prospectively the
diagnostic accuracy of AI in identifying symptomatic
plaques. The characteristics of the two groups are
summarised in Table 1.
Ultrasound plaque analysis
Non-invasive examination with colour-flow duplex-
scan was performed with ATL-HDI 3000 equipment
and the settings included the use of a 7±10 MHz
probe, 60 dB dynamic range and post-processing
linear maps.22,23
High definition images of the carotid bifurcation
were obtained and the details of the examination
have been described in previous publications.22,23
The images of the plaques were digitalized directly
into a magnetical optical disk and then loaded into a
PC type computer. Computer-assisted standardisation
and analysis was performed according the method-
ology previously published.22 The following para-
meters determined from computer-assisted analysis,
were the grey-scale median (GSM) of the histogram
representing the distribution of plaque image pixels
and also the percentile 40 (P40), that is the percentage
of `` black'' pixels (`` echolucent'' pixels) which provide
assessment of echogenicity of the plaque.
A subjective analysis of the plaques was also per-
formed based in the ultrasonographic uniformity of
plaque echo-structure appearance. When it was
regular and uniform the plaque was classified as
homogenous; if identification of areas of different
echogenicity was possible, the lesion was classified
as heterogenous and the hypo and hyper echogenicity
areas located in relation to its lumen surface.
In the subgroup of homogenous plaques the pres-
ence of the following factors was determined: global
echogenicity (GSM, P40), presence of an echogenic
cap (echogenic line visible over the structure of the
plaque) overlying the lesion, evidence of plaque sur-
face disruption, relationship between the ecogenic cap
(EC) thickness and plaque thickness. In the subgroup
of heterogenous plaques the following parameters
were reported: global echogenicity (GSM, P40), local-
isation of echolucent region of the plaque (basal or
juxta-luminal) and percentage of echolucent area in
relation to the overall plaque area. An echogenicity-
area index was also calculated by the formula:
% echolucent areaGSM of the echolucent area
/% echogenic areaGSM of the echogenic area.
In both, plaque disruption was defined by an inter-
ruption in the echogenic surface of the plaque and
power-Doppler was used in all cases to facilitate its
identification.
The degree of stenosis was quantified in all plaques
using colour-flow duplex-scan criteria: cross-section
area measurement combined with haemodynamic
assessment.
Statistical methods
In Group 1 statistical analysis was developed in 3 steps
using the software STATA 4.0.
Step 1
Univariate analysis (Chi-square and Fisher exact
test for categorial variables and variance analysis
and Student's t-test for continuous variables) were
used to determine which variables were significant
for the identification of symptomatic plaques.
Step 2
Determination of the probability ± for each significant
variable ± of occurrence of symptomatic plaque (odds
value): Oddsnumber of symptomatic plaques with
each significant variable/total number with each
significant variable.
Resizing of the odds value to a 0±100 numerical
scale was applied to determine a score for each vari-
able or subgroup inside the variable, in order that a
plaque with all significant variables present would
have a total score of 100. The AI for a given plaque
Table 1. Analysis of the characteristics of the plaques in Groups 1
and 2.
Group 1 Group 2
Patients 74 67
Men 58 (78%) 47 (70%)
Women 16 (22%) 20 (30%)
Age (years) 67 (38±80) 69 (47±88)
Plaques 106 109
Symptomatic 40 (38%) 27 (25%)
CT infarction 28
CTÿ infarction 12
Interval between symptoms and
ultrasound examination (days)
7(1±27) 5(1±35)
Asymptomatic 66 (62%) 82 (75%)
CT infarction 14
CTÿ infarction 52
% Stenosis (range) 68 (20±99) 73 (31±99)
Stenosis4 70% 54 (51%) 65 (60%)
Stenosis 51±69% 27 (25%) 32 (29%)
Stenosis5 50% 25 (24%) 12 (11%)
Homogenous 67 (63%) 71 (65%)
Heterogenous 39 (37%) 38 (35%)
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is the sum of the scores obtained for each variable
present in that lesion.
Step 3
Multivariate logistic regression analysis was used to
determine the true statistical significance of different
odds for each subgroup or variable when compared
with the respective reference group (lower probability
group).
In Group 2 the diagnostic accuracy of the AI was
assessed prospectively in a separate cohort of lesions,
where the same parameters of plaque echogenicity
and echostructure were determined following the
same methodology used in Group 1, in order to obtain
a value of AI for each plaque.
Then, the diagnostic parameters (sensitivity, speci-
ficity, positive predictive value, negative predictive
value and overall accuracy) for the identification of
the symptomatic plaque were calculated using the
ROC-curve analysis methodology.
Results
Results of the univariate analysis of the assessed param-
eters, in the subgroups of homogenous and hetero-
genous plaques and in relation with the surrogate
end-point, symptomatic and asymptomatic plaques,
are presented in Table 2.
In homogenous plaques the GSM and P40 were
significant factors, meaning that symptomatic plaques
are significantly more echolucent than asymptomatic
lesions. Also, the presence of plaque surface dis-
ruption was significantly more frequently observed
in symptomatic plaques.
Table 2. Results of the separate analysis of symptomatic and
asymptomatic plaques in Group 1.
Symptomatic Asymptomatic p
Homogenous plaque
GSM 36 46 0.03
P40 63 46 0.01
Echogenic cap 28% 41% NS
Plaque surface
disruption
53% 12% 50.01
Echogenic cap
thickness/plaque
thickness
12 12 NS
Hetereogenous plaque
GSM 31 44 0.02
P40 61 49 0.02
Plaque surface
disruption
72% 29% 50.01
Juxta-luminal location
of the echolucent
region without
echogenic cap
72% 28% 50.01
Echogenic cap
thickness/plaque
thickness
20 16 NS
% of echolucent region 59% 57% NS
Index echogenicity-area 0.5 0.5 NS
Table 3. Calculation of the odds values, odds-ratios and
confidence intervals for symptomatic plaque in the group of
Homogenous plaques (reference groups: no plaque disruption;
stenosis5 50%; GSM4 40; P405 42).
Odds Odds ratio C.I. 95% p
Homogenous plaque 0.22
Plaque surface disruption
No 0.13 ± ±
Yes 0.57 8.9 (2.3±32.9) 5 0.001
Degree of stenosis
550 0.11 ± ±
50±69 0.14 1.25 (0.1±15.8) 0.863
70±79 0.15 1.67 (0.2±1.4) 0.631
80±89 0.40 6.67 (1.9±25.8) 0.032
490 0.50 10.0 (1.6±33.1) 0.014
GSM
520 0.80 37.3 (3.1±63.0) 50.001
20±32 0.38 11.2 (2.2±56.1) 50.001
33±40 0.18 5.6 (1.2±26.7) 0.031
440 0.09 ± ± ±
P40
542 0.07 ± ± ±
42±55 0.18 4.9 (2±35) 0.036
56±63 0.27 6.5 (1.2±32.4) 0.021
463 0.47 11.4 (2.0±36.1) 50.001
Table 4. Calculation of the odds values, odds-ratios and confi-
dence intervals for symptomatic plaque in the group of Hetero-
genous plaques (reference groups: homogenous plaque; central
echolucent region; no plaque disruption; stenosis5 50%;
GSM4 40; P405 42).
Odds Odds ratio C.I. 95% p
Heterogenous plaque 0.64 6.19 (2.6±14.8) 50.001
Location of the
echolucent region
Central 0.14 ± ± ±
Juxta-luminal 0.72 6.8 (1.8±21.2) 0.021
Plaque surface disruption
No 0.41 ± ± ±
Yes 0.82 6.4 (1.5±27.4) 50.001
Degree of stenosis
550 0.00 ± ± ±
50±69 0.14 ± ± ±
70±79 0.43 5.9 (2.4±10.7) 0.034
80±89 0.57 6.6 (3.7±12.5) 0.020
490 1.00 22.1 (4.5±121.7) 50.001
GSM
520 1.00 7.2 (1.7±29.6) 0.011
20±32 0.57 3.2 (0.9±10.7) 0.061
33±40 0.42 2.5 (0.7±10.1) 0.121
440 0.12 ± ± ±
P40
442 0.23 ± ± ±
42±55 0.44 2.7 (0.7±10.9) 0.288
56±63 0.53 3.3 (0.8±12.6) 0.092
463 1.00 9.7 (1.8±26.6) 50.001
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In heterogenous plaques, the GSM and P40 were
also significantly different in symptomatic lesions
meaning that symptomatic plaques are more echo-
lucent. Plaque surface disruption was more frequently
observed in symptomatic plaques and the juxta-
luminal location of the echolucent region, without
echogenic cap, was also a characteristic of sympto-
matic plaques.
Assessment of the relative importance of each
significant parameter by calculation of the probability
values is presented in Tables 3 and 4.
The re-sizing of these odds value for a 0±100 scale
allowed the determination of a numerical score indi-
cated in Table 5. The AI of each plaque was obtained
by the sum of these scores.
A plaque with heterogenous structure, with a juxta-
luminal echolucent area, degree of stenosis490%;
GSM5 32; and P404 42 would be associated with
maximal AI of 100.
The analysis by multivariate logistic regression
showed that the increases in probability in the groups
of stenosis 50±69% and 70±79% (against stenosis5
50%), for homogenous plaques, were not statistically
significant. The same happened in the heterogenous
plaques population relative to stenosis 50±69%, GSM
20±40 and P40 42±63. In spite of these results, prob-
ability value of symptomatic plaque for each class was
accepted and the correspondent small score increase
has been included in Table 5.
Applied on group 2, the mean AI in symptomatic
plaques was 75 (41±100) and in asymptomatic plaques
43 (22±100). Figure 1 shows the distribution of the AI
in the various intervals and in both symptomatic and
asymptomatic plaques. It is aparent that 93% of symp-
tomatic plaques have an AI superior to 50 and 78%
superior to 60. Eighty two percent of asymptomatic
plaques have an AI lower than 60 and 70% lower than
50. The cut-off point between the two groups, allow-
ing the greater discrimination between them, is the
value of 52 (Fig. 1).
The calculation of diagnostic parameters using
ROC curve analysis shows that the best cut-off level
for the AI in homogenous plaques (Fig. 2) is the value
53±60, associated with sensitivity of 56%, specificity
of 92%, positive predictive value of 50%, negative
predictive value of 93% and accuracy of 87%. For
`` Score'' `` Score''
Homogenous plaque 9 Heterogenous plaque 12
Plaque surface disruption Location of the echolucent region
No 5 Central with echogenic cap 3
Yes 22 Juxta-luminal without echogenic cap 14
Degree of stenosis Plaque surface disruption
550 4 No 8
50±69 5 Yes 16
70±79 6 Degree of stenosis
80±89 16 550 0
490 20 50±69 3
GSM 70±79 8
520 31 80±89 11
20±32 15 490 19
33±40 7 GSM
440 4 520 19
P40 20±32 11
543 3 33±40 8
43±55 7 440 2
56±63 11 P40
463 18 543 4
43±55 9
56±63 10
463 19
Table 5. `` Scores'' for calculation of the Activity Index (symptomatic plaque).
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heterogenous plaques (Fig. 3) the best cut-off levels
were the values 52±53, associated with sensitivity of
89%, specificity of 43±48%, positive predictive value of
59%, negative predictive value of 83±100% and accur-
acy of 75±76%.
Discussion
Major trials have shown that the degree of stenosis is
the most important factor in the requirement for
intervention in patients with carotid disease.1±3
Nevertheless, plaque characteristics, such as
intra-plaque haemorrhage4,5,7 and ulceration,8 a
wide 24,25 and juxta-luminal lipid/necrotic centre13 a
thin or ruptured fibrous cap8,26,27 and an increased
infiltration by inflammatory cells, constitute markers
of instability and clinical risk.28,29 Also a higher
lipid28,30,31 and blood content may increase the plaque
susceptibility to haemodynamic stresses.32±35
The European Carotid Stenosis Trial (ECST) found
that the markers of risk for neurological events at
2 years were the degree of stenosis and the presence
of plaque surface irregularity on angiography.36
New generation of colour-flow duplex scanners
with improved quality of the high definition
ultrasonographic image, and the introduction of
computer-assisted carotid plaque analysis with digital
image processing and standardisation, permit a more
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Fig. 1. Distribution of symptomatic and asymptomatic plaques at Activity Index intervals.
Sens Spec PPV NPV Accuracy
>40 100 62 29 100 72
>45 89 83 44 98 86
>50 78 87 47 96 86
>51 67 87 46 96 96
>52 56 88 50 95 87
>53 56 92 50 93 87
>60 56 92 50 93 87
>65 33 93 43 90 86
>70 11 95 25 88 84
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Fig. 2. Diagnostic accuracy (ROC-curve) of the Activity Index in
the identification of the symptomatic in homogenous plaques
(Group 2).
IA Sens Spec PPV NPV Acuracy
>40 100 46 68
>45 100 24 46 100 73
>50 100 29 53 100 74
>51 89 29 59 100 74
>52 89 43 59 100 75
>53 89 48 59 83 76
>55 89 52 59 83 76
>60 89 67 73 83 80
>70 72 81 77 77 80
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Fig. 3. Diagnostic accuracy (ROC-curve) of the Activity Index in
the identification of the symptomatic in heterogenous plaques
(Group 2).
496 L. M. Pedro et al.
Eur J Vasc Endovasc Surg Vol 24, December 2002
objective and reproducible study of plaque structure21
and stability.37,38
The present study take this knowledge forward
through the development of a plaque activity (AI).
This Index was obtained by a projection into a
numerical scale of the probability values of occurrence
of symptomatic plaque for each studied ecographic
parameter obtained by high definition ultrasono-
graphy and computer-assisted image analysis, aiming
to determine its relative weight. It was also used to
acomodate even small and non significant differences
between the various parameters by multivariate logis-
tic regression analysis, in order to maximise the dis-
criminatory power of the AI to separate between
symptomatic and asymptomatic carotid lesions.
In our study this AI was shown to correlate
with clinically symptomatic lesions, that is, causing
appropriate neurologic symptoms in the carotid
territory.
The overall diagnostic power of AI to identify the
symptomatic lesion was subsequently studied in a
different population of plaques, the results obtained
were extremely satisfactory and the use of ROC curves
allowed the identification of different cut-off values of
Al with higher diagnostic specificity or sensitivity.
However, to evaluate the predictive power of AI to
identify instability in asymptomatic plaques prone to
develop symptoms, further research using this param-
eter in studies of natural history in patients with
carotid disease will be required.
Also the identification of a subset of `` dangerous''
plaques, with higher neurological risk, may have
important implications in the indication for carotid
endarterectomy, as it is well known that the absolute
benefit of surgical treatment is low in the asympto-
matic disease3 and in symptomatic disease ass-
ociated with moderate degree of stenosis.40
Meanwhile, AI is an objective parameter that cor-
relates with plaque instability and clinical activity
and its use may enhance objectivity in the assessment
of carotid plaque structure using high definition
ultrasonography.
Acknowledgment
To Dr Sofia Guerreiro for the statistical analysis performed and
mathematical assistance.
References
1 European Carotid Surgery Trialists' Collaborative Group.
MRC European Carotid Surgery Trial. Interin results for sympto-
matic patients with severe (70±99%) and with mild (0±29%)
stenosis. Lancet 1991; 337: 1235±1243.
2 North American Symptomatic Carotid Endarterectomy
Trial Collaborators. Beneficial effect of carotid endarterec-
tomy in symptomatic patients with high grade carotid stenosis.
N Engl J Med 1991; 325: 445±463.
3 Executive Committee for the Asymptomatic Carotid
Atherosclerosis Study. Endarterectomy for asymptomatic
carotid artery stenosis. JAMA 1995; 273: 1421±1428.
4 Lusby RJ, Ferrell LD, Ehrenfeld WK et al. Carotid plaque
hemorrhage: its role in production of cerebral ischemia. Arch
Surg 1982; 117: 1479.
5 Imparato AM, Riles TS, Mintzer R et al. The importance of
hemorrhage in the relationship between gross morphologic
characteristics and cerebral symptoms in 376 carotid artery
plaques. Ann Surg 1983; 197: 195.
6 Zukowski AJ, Nicolaides AN, Lewis RT et al. The correlation
between carotid plaque ulceration and cerebral infarction on CT
scan. J Vasc Surg 1984; 1: 782.
7 Persson AV. Intraplaque hemorrhage. Surg Clin North Am 1986;
66: 415.
8 Carr S, Farb A, Pearce WH et al. Atherosclerotic plaque rupture
in symptomatic carotid artery stenosis. J Vasc Surg 1996; 23: 755.
9 Imparato AM, Riles TS, Gorstein F. The carotid bifurcation
plaque: pathologic findings associated with cerebral ischemia.
Stroke 1979; 10: 238.
10 Avril G, Batt M, Guidoin R et al. Carotid endarterectomy
plaques: correlation of clinical and anatomic findings. Ann Vasc
Surg 1991; 5: 50.
11 Feeley TM, Leen EJ, Colgan MP et al. Histologic characteristics
of carotid artery plaque. J Vasc Surg 1991; 13: 719.
12 Carr SC, Cheanvechai MD, Virmani RV et al. Histology
and clinical significance of the carotid atherosclerotic plaque:
implications for endovascular treatment. J Endovasc Surg 1997;
4: 325.
13 Bassiouny HS, Sakaguchi Y, Mikucki SA et al. Juxtalumenal
location of plaque necrosis and neoformation in symptomatic
carotid stenosis. J Vasc Surg 1997; 26: 585.
14 Reilly LM, Lusby RJ, Hughes L. Carotid plaque histology using
real-time ultrasonography. Am J Surg 1983; 146: 188±193.
15 Ratliff DA, Gallagher PJ, Hames TK et al. Characterization of
carotid artery disease: comparison of duplex scan with histology.
Ultrasound Med Biol 1985; 11: 835.
16 O'Donnell TF, Erdoes L, Mackey WC et al. Correlation of
B-Mode ultrasound imaging and arteriography with pathologic
findings at carotid endarterectomy. Arch Surg 1985; 120: 443.
17 Reilly LM. Carotid intraplaque hemorrhage: non-invasive
detection and clinical significance. In: Bernstein EF, ed.
Non-Invasive Diagnostic Techniques in Vascular Surgery. The C.V.
Mosby Company, 1990; 99.
18 Geroulakos G, Ramaswami G, Nicolaides AN et al. Charac-
terization of symptomatic and asymptomatic carotid plaques
using high-resolution real-time ultrasonography. Br J Surg 1993;
80: 1274.
19 El-Barghouty, Geroulakos G, Nicolaides AN et al.
Computer-assisted carotid plaque characterization. Eur J Vasc
Endovasc Surg 1995; 9: 389.
20 El-Barghouty, Nicolaides NA, Bahal V et al. The identifica-
tion of the high risk carotid plaque. Eur J Vasc Endovasc Surg 1996;
11: 470.
21 Elatrozy T, Nicolaides A, Tegos T et al. The effect of B-mode
ultrasonic image standardisation on the echodensity of sympto-
matic and asymptomatic carotid bifurcation plaques. Int Angiol
1998; 17: 179±186.
22 Pedro LM, Pedro MM, GoncËalves I et al. Computer-assisted
carotid plaque analysis: characteristics of plaques associated
with cerebrovascular symptoms and cerebral infarction. Eur J
Vasc Endovasc Surg 2000; 19: 118±123.
23 Pedro LM, Pedro MM, GoncËalves I et al. How to identify the
active carotid atherosclerotic plaque. Rev Port Cardiol 1999; 18:
699±708.
24 Gertz SD, Roberts WC. Hemodynamic shear force in rupture of
coronary arterial atherosclerotic plaques. Am J Cardiol 1990; 66:
1368±1372.
Risk Score of Carotid Plaques 497
Eur J Vasc Endovasc Surg Vol 24, December 2002
25 Davies MJ, Richardson PW, Woolf N et al. Risk of thrombosis
in human atherosclerotic plaques: role of extracellular lipid,
macrophage and smooth muscle cell content. Br Heart J 1993;
69: 377±381.
26 Loree HM, Kamm RD, Stringfellow RG, Lee RT. Effects of
fibrous cap thickness on peak circunferencial stress in model
atherosclerotic vessels. Circ Res 1992; 71: 850±858.
27 Burleigh MC, Briggs AD, Lendon CL et al. Collagen types I
and III, collagen content, GAGs and mechanical strength of
human atherosclerotic plaque caps. Atherosclerosis 1992; 96:
71±81.
28 Gronholdt ML. Ultrasound and lipoproteins as predictors of
lipid-rich, rupture-prone plaques in the carotid artery. Arterios-
cler Thromb Vasc Biol 1999; 19: 2±13.
29 Van de Wal AC, Becker AE, van der Loos CM, Das PK.
Site of intimal rupture or erosion of thrombosed coronary
atherosclerotic plaques is characterized by an inflammatory
process irrespective of the dominant plaque morphology.
Circulation 1994; 89: 36±44.
30 Gronholdt ML, Nordestgaard BG, Wiebe BM. Echolucency
of computerized ultrasound images of carotid atherosclerotic
plaques are associated with increased levels of triglyceride-rich
lipoproteins as well as increased plaque lipid content. Circulation
1998; 97: 34±40.
31 Gronholdt ML, Wiebe BM, Laursen H et al. Lipid-rich carotid
artery plaques appear echolucent on ultrasound B-mode images
and may be associated with intraplaque haemorrhage. Eur J Vasc
Endovasc Surg 1997; 14: 439±445.
32 Libby P. The interface of atherosclerosis and thrombosis: basic
mechanisms. Vascular Medicine 1998; 3: 225±229.
33 Fuster V, Badimon JJ, Chesebro. Atherothrombosis: mech-
anisms and clinical therapeutical approaches. Vasc Med 1998; 3:
231±239.
34 Lammie GA, Path MR, Sandercock PA, Dennis MS. Recently
occluded intracranial and extracranial carotid arteries. Relevance
of the unstable atherosclerotic plaque. Stroke 1999; 30: 1319±1325.
35 Torvik A, Svindland A, Lindboe CF. Pathogenesis of carotid
thrombosis. Stroke 1989; 20: 1477±1483.
36 Rothwell PM, Gibson R, Warlow CP et al. Interrelation
between plaque surface morphology and degree of stenosis
on carotid angiograms and the risk of ischemic stroke in
patients with symptomatic carotid stenosis. Stroke 2000; 31:
615±621.
37 Sabetai MM, Tegos TJ, Nicolaides AN et al. Hemispheric
symptoms and carotid plaque echomorphology. J Vasc Surg
2000; 31: 39±49.
38 Biasi GM, Mingazzini P, Baronio L et al. Carotid plaque
characterization using digital image processing and its potential
in future studies of carotid endarterectomy and angioplasty.
J Endovasc Surg 1998; 5: 240±246.
39 Barnett HJ, Taylor DW, Eliasziw M et al. Benefit of carotid
endarterectomy in patients with symptomatic moderate or
severe stenosis. N Engl J Med 1998; 339: 1415±1425.
Accepted 13 August 2002
498 L. M. Pedro et al.
Eur J Vasc Endovasc Surg Vol 24, December 2002
